Kanvas Biosciences Secures $48M Series A to Deliver Novel Microbiome Therapeutics to Cancer Patients

May 6

Written By Tomoko Saeki

Japan medical startups need more than tech to break into US: VC executive

Behavidence Launches Clinical Partnership Program to Advance Mental Health RTM with Passive Digital Biomarkers